Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-27
DOI
10.3389/fphar.2020.596230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2019) J. A. Kanis et al. CALCIFIED TISSUE INTERNATIONAL
- Immune Function and Diversity of Osteoclasts in Normal and Pathological Conditions
- (2019) Maria-Bernadette Madel et al. Frontiers in Immunology
- Inhibition of osteoclastogenesis by mechanically stimulated osteoblasts is attenuated during estrogen deficiency
- (2019) Hollie Allison et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Diagnosis of osteoporosis in statin-treated patients is dose-dependent
- (2019) Michael Leutner et al. ANNALS OF THE RHEUMATIC DISEASES
- Juglanin inhibits IL-1β-induced inflammation in human chondrocytes
- (2019) Xinxin Chen et al. Artificial Cells Nanomedicine and Biotechnology
- Bisphosphonates for Postmenopausal Osteoporosis
- (2019) Kristine E. Ensrud et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Update on Menopausal Hormone Therapy for Fracture Prevention
- (2019) Jan J. Stepan et al. Current Osteoporosis Reports
- Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway
- (2018) Fang-Xue Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Juglanin ameliorates UVB‑induced skin carcinogenesis via anti‑inflammatory and proapoptotic effects in vivo and in vitro
- (2018) Gui‑Rong Hou et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Estrogen therapy for osteoporosis in the modern era
- (2018) V. A. Levin et al. OSTEOPOROSIS INTERNATIONAL
- Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-κB/ERK signaling pathway in Raw264.7 cells.
- (2018) Buyun Kim et al. PHYTOMEDICINE
- 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
- (2018) Xiao Chen et al. Frontiers in Pharmacology
- Coupling of bone resorption and formation by RANKL reverse signalling
- (2018) Yuki Ikebuchi et al. NATURE
- RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment
- (2018) Peter A. van Dam et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors
- (2017) Zhenqiang Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pmepa1 induced by RANKL-p38 MAPK pathway has a novel role in osteoclastogenesis
- (2017) Noboru Funakubo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The many ways of osteoclast activation
- (2017) Joseph Lorenzo JOURNAL OF CLINICAL INVESTIGATION
- Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice
- (2017) Zhen Tan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
- (2017) Liang Chen et al. Oncotarget
- Protocatechuic acid inhibits osteoclast differentiation and stimulates apoptosis in mature osteoclasts
- (2016) Yi-Xin Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways
- (2016) Lin Zhou et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation
- (2016) Yuvaraj Sambandam et al. Scientific Reports
- Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression
- (2015) Xiang-zhou Zeng et al. ACTA PHARMACOLOGICA SINICA
- HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors
- (2013) A. Gabrielle J. van der Kraan et al. BIOCHEMICAL JOURNAL
- Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors
- (2012) Preetinder P. Singh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now